Equity
€456,099 ▲ 32.1%
VASKO has made a profit in every financial year since 2019.
VASKO
Lifetime
7 annual accounts with figures on one time axispeak of €264,330 in 2025
€264,330▲ 19.8%
peak of €143,214 in 2025
€143,214▲ 26.8%
peak of €456,099 in 2025
€456,099▲ 32.1%
€171,795▼ 20.5%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
18-02-202671 days before the deadline
2025micro format
Gross margin from €220,608 to €264,330Result from €112,922 to €143,214Dividend €38,500Equity from €345,185 to €456,099Debts from €216,049 to €171,795Cash from €369,217 to €78,452
Key points
from the 2025 annual accountsTurnover
≈ €400,000 estimated
The micro format states no turnover.
Liquidity
7.75 was 5.31 in 2024
Short-term debts fell from €77,420 to €67,324.
Filings
7 annual accounts since 2019
The last five annual accounts were filed 1 to 71 days before the end of the period.
Starting capital
€18,600 186 shares
Position in the sector
€456,099
More equity than 80% of companies in human health. Sector median €125,024 · 21,336 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,783 companies had the same profile as VASKO has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,783 companies, not a prediction for VASKO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 13-06-2018
Manager, since 13-06-2018
- founderdeed of 15-06-2018
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0697858382
Company renamed from Dr. , vasculair en thoracaal chirurg to VASKO
Change of role: , from manager to director · Gazette deed
Registered office moved from Zemst to Hofstade
The registered office moved from TERVUURSESTEENWEG 798 TE 1982 ZEMST to Hofgrachtlaan 22 te 1981 Hofstade · General meeting of 18-07-2022 · Gazette deed
Registered office moved from Ghent to Elewijt
The registered office moved from KRIJGSLAAN 67 TE 9000 GENT to Tervuursesteenweg 798 te 1982 Elewijt · General meeting of 06-05-2019 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| VASKO Zemst | €627,894 | €264,330 | 72.6% | - |
| Dr. C. Prégardien, anesthesist Kortenberg | €614,310 | €259,786 | 58.1% | - |
| Dr. E. Keersebilck Ostend | €620,711 | €252,387 | 96.6% | - |
| FACIAL SURGERY Ixelles | €665,880 | €276,195 | 18.6% | - |
| Stégil Braine-l'Alleud | €583,669 | €260,029 | 37.5% | - |
| Dokter Petra Belkova Cardiologe Beveren-Kruibeke-Zwijndrecht | €578,223 | €259,776 | 37.6% | - |
| HAMEURLAINE SELMA Jette | €568,075 | €265,865 | 87.9% | - |
These companies have the same main activity as VASKO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €568,000 and €666,000, founded in 2018.
Official details
Source: KBO- Status
- Active since 13-06-2018Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.279.055.8771981 Zemst, registered on 13-06-2018
- Financial year end
- 30 September
- Peppol
- Reachable since 12-12-2025
Annual accounts to 30-09-2025
- €627,894▲ 11.9%
- Filing
- Filed on 18-02-2026, 71 days before the end of the filing period
Insights on VASKO
VASKO files the micro format. That format states no turnover. The gross margin rose from €128,134 in 2019 to €264,330 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about VASKO
- What is the company number of VASKO?
- The company number of VASKO is 0697.858.382. The VAT number is the same number with BE in front: BE 0697.858.382.
- Where is VASKO based?
- The registered office is at Hofgrachtlaan 22, 1981 Zemst.Company details
- What does VASKO do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of VASKO?
- VASKO is a private limited company (BV).
- When was VASKO founded?
- VASKO was founded on 13-06-2018.
- Is VASKO still active?
- Yes, VASKO is an active enterprise in the KBO register.
- What is the turnover of VASKO?
- The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €264,330 and 31 comparable companies (NACE 86220). It probably lies between €350,000 and €550,000.Financials
- Is VASKO profitable?
- In financial year 2025, VASKO made a profit of €143,214.
- Where can I find the annual accounts of VASKO?
- VASKO filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of VASKO due?
- VASKO must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.